Results 31 to 40 of about 20,467 (239)

Diabetic Macular Edema With and Without Subfoveal Neuroretinal Detachment: Two Different Morphologic and Functional Entities [PDF]

, 2017
To assess specific morphologic and functional characteristics in eyes with diabetic macular edema (DME) with subfoveal neuroretinal detachment (SND+) vs DME without SND (SND-)
Berton, Marianna, Bini, Silvia, Convento, Enrica, Midena, Edoardo, Torresin, Tommaso, Vujosevic, Stela   +5 more
core   +1 more source

Remote examination of exudates-impact of macular oedema

Healthcare Technology Letters, 2018
One of the major causes of eye blindness is identified to be as diabetic retinopathy, which if not detected in earlier stage would cause a serious issue. Long-term diabetes causes diabetic retinopathy.
Uma Punniyamoorthy, Indumathi Pushpam
doaj   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T., Bonfiglio V., Fallico M., Fichera S., Longo A., Macchi I., Pizzo A., Rapisarda C., Reibaldi M., Russo A.   +9 more
core   +2 more sources

Comparison between “early” or “late” intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six months follow-up [PDF]

, 2017
AIM: The aim of this study was to compare early and late injections of intravitreal dexamethasone implant in patients affected by central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) with a six-months follow-up.
AUTOLITANO, MONICA, BASILI, Stefania, LA TORRE, Giuseppe, LENZI, TOMMASO, PACELLA, Elena, PACELLA, FERNANDA, Pascarella, Antonella   +6 more
core   +1 more source

Preliminary Report on Optical Coherence Tomography Angiography Biomarkers in Non-Responders and Responders to Intravitreal Anti-VEGF Injection for Diabetic Macular Oedema

Diagnostics, 2023
Purpose: To identify optical coherence tomography angiography (OCTA) biomarkers in patients who were treated for diabetic macular oedema (DME) with intravitreal anti-vascular endothelial growth factor (VEGF) injections and compare the OCTA parameters ...
Sanjana Chouhan, Rekha Priya Kalluri Bharat, Janani Surya, Sashwanthi Mohan, Janarthanam Jothi Balaji, V. K. Viekash, Vasudevan Lakshminarayanan, Rajiv Raman   +7 more
doaj   +1 more source

Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme [PDF]

, 2014
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.Peer reviewedPublisher ...
A D Morris, Cheng, D T Cromie, D W M Pearson, Elman, G P Leese, Ghafour, H C Looker, H M Colhoun, Hammes, J A McKnight, J A Olson, J Doig, Klein, Klein, Klein, Kohner, LeCaire, Leese, Leese, Looker, Looker, M W Black, Misra, Murgatroyd, N Lee, Olson, Pandit, Philip, R S Lindsay, Roy, S H Wild, S O Nyangoma, S Philip, Stratton, van Leiden, Zhang   +36 more
core   +7 more sources

Changes in Macular Oedema by Optical Coherence Tomography in Patients Receiving Intravitreal Bevacizumab: A Retrospective Observational Hospital Based Study [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Collection of fluid in the macula is called macular oedema. It is a manifestation of various pathologies, main being diabetic retinopathy. Since the burden of the disease is immense and can cause blindness, its early detection and treatment
Ajit K Joshi, Nimisha Lahkar, Paurnima U Bodhankar, Abhinandan N Patil   +3 more
doaj   +1 more source

Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion [PDF]

, 2016
No abstract ...
Abdolrahimzadeh, Solmaz, Plateroti, ANDREA MARIA, Plateroti, Pasquale, Scarinci, Fabio   +3 more
core   +1 more source

An in vivo evaluation of Brilliant Blue G in animals and humans [PDF]

, 2008
Background/Aims: To evaluate the retinal toxicity of Brilliant Blue G (BBG) following intravitreal injection in rat eyes and examine the biocompatibility and the staining properties in humans.Methods: BBG was injected into the 11 rat eyes to evaluate ...
Fiedorowicz, M., Grüterich, Martin, Haritoglou, Christos, Kampik, Anselm, May, C. A., Nentwich, Martin M., Priglinger, Siegfried G., Remy, M., Schuettauf, F., Schumann, Ricarda G., Thaler, S.   +10 more
core   +1 more source

Multiple myeloma masquerading as diabetic macular oedema [PDF]

BMJ Case Reports, 2018
A 58-year-old man, a known diabetic and hypertensive for 5 years was presented to us with a drop in reading vision in both eyes of 2 months duration. His best-corrected visual acuity was 6/24, N36 in both eyes. Fundus findings revealed moderate non-proliferative diabetic retinopathy with bilateral diffuse macular oedema.
Kavitha, Rao, Hemanth, Murthy, N S, Muralidhar, Padmaja Kumari, Rani   +3 more
openaire   +2 more sources